Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |